We're working on adding all of our packages. Stay tuned or get in touch if you don't see what you're looking for!

Disease Prioritization Data Package

This package has 16 modules. The Rare Diseases Module has 5 tables. Preview the first five rows of each table or Explore the schema

Rare Diseases Module

5 Tables

Describes the status of a drug intended for use against rare diseases. The dataset offers a view of the orphan designations without being specifically tied to any one set of regulatory standards or rules.

Clinical Trial Bio-Entities

Lists biological entities mentioned and the trials in which the biological entity was mentioned.

id
trial_id
biodb_id
label
3
NCT02836340
BE0004550
protein
8
NCT02836340
BE0001177
protein
13
NCT04143295
BE0000178
protein
18
NCT04143295
BE0000178
gene
23
NCT01337986
BE0009847
gene
Want all 16,650 rows? Let's connect you to sales.

Clinical Trial Bio-Entities Strings

Describes the section of the clinical trial registry data in which the biological entity was mentioned.

id
mention_id
string
section
3
3
NSE
description
8
8
s100b
description
13
13
MCT8
description
18
13
MCT8
title
23
13
MCT8
official_title
Want all 34,582 rows? Let's connect you to sales.

Orphan Designations

Describes the orphan designations for rare diseases without being specifically tied to any one set of regulatory standards or rules.

id
condition_id
source
designation_status
designation_date
2
7749
FDA
designated_withdrawn
2015-05-04
7
157373
FDA
designated
2017-07-03
12
550
FDA
designated
2007-12-18
17
38696
FDA
designated
1996-10-29
22
71340
FDA
designated_withdrawn
1993-11-22
Want all 5,956 rows? Let's connect you to sales.

Orphan Designation Drugs

Join table associating drugs with their orphan designations. Each orphan designation has one or more drugs.

id
drug_id
orphan_designation_id
2
12476
2
7
27573
7
12
27578
12
17
1050
17
22
27598
22
Want all 6,253 rows? Let's connect you to sales.

Orphan FDA Designations

This table stores information about FDA designations for orphan designations.

cf_grid_key
orphan_designation_id
generic_name
orphan_designation
designation_date
designation_status
marketing_approval_date
exclusivity_end_date
approved_labeled_indication
exclusivity_protected_indication
000183
22170
physostigmine salicylatephysostigmine salicylate
Treatment of Friedreich's and other inherited ataxias.
1985-01-16
designated_withdrawn
000383
29221
Diaziquone
Treatment of primary brain malignancies (grade III and IV astrocytomas).
1983-11-10
designated_withdrawn
000583
28700
Selegiline HCl
As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.
1984-11-07
designated_approved
1989-06-05
1996-06-05
000683
25260
Hemin
Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria.
1984-03-16
designated_approved
1983-07-20
1990-07-20
000883
10492
Teniposide
Treatment of refractory childhood acute lymphocytic leukemia.
1984-11-01
designated_approved
1992-07-14
1999-07-14
Induction therapy in patients with refractory childhood acute lymphoblastic leukemia when used in combination with other approved anticancer agents.
Want all 5,963 rows? Let's connect you to sales.

Showing 5 of 5 tables